Recruiting Amyloidosis Studies in Indianapolis
About Amyloidosis Clinical Trials in Indianapolis
Amyloidosis is a group of diseases in which abnormal proteins (amyloids) build up in organs and tissues, impairing their function. Types include AL, AA, and ATTR amyloidosis. Treatment depends on the type and may include chemotherapy, organ transplant, or targeted therapies.
There are currently 1 amyloidosis clinical trials recruiting participants in Indianapolis, IN. These studies are seeking a combined 1,850 participants. Research is being sponsored by AstraZeneca. Clinical trial participation is free and participants receive study-related medical care at no cost.
Amyloidosis Clinical Trials in Indianapolis — FAQ
Are there amyloidosis clinical trials in Indianapolis?
Yes, there are 1 amyloidosis clinical trials currently recruiting in Indianapolis, IN. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Indianapolis?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Indianapolis research site will contact you about next steps.
Are clinical trials in Indianapolis free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Indianapolis studies also compensate for your time and travel.
What amyloidosis treatments are being tested?
The 1 active trials in Indianapolis are testing new therapies including novel drugs, biologics, and treatment approaches for amyloidosis.
Data updated July 13, 2026 from ClinicalTrials.gov